Published in Lancet on January 16, 1993
Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis (2009) 4.05
Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal. PLoS Negl Trop Dis (2012) 2.42
Blindness in the developing world. Br J Ophthalmol (1993) 2.26
Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control. Parasit Vectors (2012) 2.08
Computerized motion sensitivity screening tests in a multicountry rural onchocercal community survey in Africa. Middle East Afr J Ophthalmol (2010) 1.71
Ivermectin and onchocercal optic nerve lesions. Lancet (1993) 1.40
Red-dot card test of the paracentral field as a screening test for optic nerve disease in onchocerciasis. Bull World Health Organ (1996) 1.18
Impact of annual dosing with ivermectin on progression of onchocercal visual field loss. Bull World Health Organ (1997) 1.00
Ocular onchocerciasis: current management and future prospects. Clin Ophthalmol (2011) 0.98
An immunohistochemical analysis of onchocercal nodules: evidence for an interaction between macrophage MRP8/MRP14 and adult Onchocerca volvulus. Clin Exp Immunol (1993) 0.87
Ivermectin for onchocercal eye disease (river blindness). Cochrane Database Syst Rev (2012) 0.84
Molecular and immunological characterization of hr44, a human ocular component immunologically cross-reactive with antigen Ov39 of Onchocerca volvulus. J Exp Med (1995) 0.82
Preventing blindness worldwide. BMJ (1994) 0.78
Sustainable control of onchocerciasis: ocular pathology in onchocerciasis patients treated annually with ivermectin for 23 years: a cohort study. PLoS One (2014) 0.77
Blindness: how to assess numbers and causes? Br J Ophthalmol (2003) 0.77
Predictors of compliance with community-directed treatment with ivermectin for onchocerciasis control in Kabo area, southwestern Ethiopia. Parasit Vectors (2015) 0.76
Pre-control relationship of onchocercal skin disease with onchocercal infection in Guinea Savanna, Northern Nigeria. PLoS Negl Trop Dis (2017) 0.75
Recent advances in tropical medicine. BMJ (1994) 0.75
Blue-yellow colour vision in an onchocercal area of northern Nigeria. Br J Ophthalmol (1998) 0.75
Impact of Eighteen-Year Varied Compliance to Onchocerciasis Treatment with Ivermectin in Sentinel Savannah Agrarian Communities in Kaduna State of Nigeria. ISRN Parasitol (2013) 0.75
A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15
A simple system for the assessment of trachoma and its complications. Bull World Health Organ (1987) 12.27
Detection of Chlamydia (Bedsonia) in certain infections of man. II. Clinical study of genital tract, eye, rectum, and other sites of recovery of Chlamydia. J Infect Dis (1969) 6.76
Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med (2001) 6.67
Modification of the microimmunofluorescence test to provide a routine serodiagnostic test for chlamydial infection. J Clin Pathol (1977) 6.48
Inhibition of nuclear protein import by nonhydrolyzable analogues of GTP and identification of the small GTPase Ran/TC4 as an essential transport factor. J Cell Biol (1993) 6.47
Chlamydial infection. Incidence in 'non-specific' urethritis. Br J Vener Dis (1972) 6.04
Blinding and non-blinding trachoma: assessment of intensity of upper tarsal inflammatory disease and disabling lesions. Bull World Health Organ (1975) 5.58
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst (1996) 5.28
U.K. guidelines for the management of cutaneous melanoma. Br J Dermatol (2002) 4.92
The prevention of blindness from trachoma. Trans Ophthalmol Soc U K (1975) 4.80
Infection by Bedsoniae and the possibility of spurious isolation. 2. Genital infection, disease of the eye, Reiter's disease. Am J Ophthalmol (1967) 4.73
Chlamydial infection. Results of micro-immunofluorescence tests for the detection of type-specific antibody in certain chlamydial infections. Br J Vener Dis (1972) 4.50
Conjunctival swabbing for the isolation of TRIC agent (Chlamydia). Br J Ophthalmol (1971) 4.01
Dehydrational crises from severe diarrhoea or heatstroke and risk of cataract. Lancet (1984) 3.70
A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium. N Engl J Med (1998) 3.62
UK guidelines for the management of cutaneous melanoma. Br J Plast Surg (2002) 3.51
Chlamydial infection. Advances in the diagnostic isolation of Chlamydia, including TRIC agent, from the eye, genital tract, and rectum. Br J Vener Dis (1972) 3.41
Amoebic infection of the eye. Lancet (1974) 3.27
Child mortality in a West African population protected with insecticide-treated curtains for a period of up to 6 years. Bull World Health Organ (2004) 3.06
Predicting the CJD epidemic in humans. Nature (1997) 3.04
Efficacy of acycloguanosine (Wellcome 248U) against herpes-simplex corneal ulcers. Lancet (1979) 2.90
The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med (1998) 2.73
Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities, Kaduna State, Nigeria. Kaduna Collaboration for Research on Onchocerciasis. Br J Ophthalmol (1994) 2.47
Infection by TRIC agent and other members of the Bedsonia group; with a note on Reiter's disease. II. Ophthalmia neonatorum due to TRIC agent. Trans Ophthalmol Soc U K (1966) 2.46
Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol (2000) 2.42
Double-blind trial of the treatment of episcleritis-scleritis with oxyphenbutazone or prednisolone. Br J Ophthalmol (1966) 2.41
Outcome of pregnancy in a woman with an increased body mass index. BJOG (2005) 2.38
Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers. Am J Ophthalmol (1972) 2.37
Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agents. Lancet (1995) 2.36
Design and analysis issues in cluster-randomized trials of interventions against infectious diseases. Stat Methods Med Res (2000) 2.36
Influence of ethnic origin on the incidence of keratoconus and associated atopic disease in Asians and white patients. Eye (Lond) (2004) 2.34
Views of junior doctors about their work: survey of qualifiers of 1993 and 1996 from United Kingdom medical schools. Med Educ (2000) 2.29
Principles in the management of oculomycosis. XXXI Edward Jackson memorial lecture. Am J Ophthalmol (1975) 2.29
Effect of high-speed centrifugation on the sensitivity of irradiated McCoy cell culture for the isolation of Chlamydia. Br J Vener Dis (1974) 2.28
Rapid serological test for diagnosis of chlamydial ocular infections. Br J Ophthalmol (1978) 2.25
Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery an independent determinant of prognosis? Am J Obstet Gynecol (1992) 2.24
Impact of fly control on childhood diarrhoea in Pakistan: community-randomised trial. Lancet (1999) 2.23
alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci U S A (1997) 2.19
Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol (1985) 2.18
Clinical predictors of admission in infants with acute bronchiolitis. Arch Dis Child (2011) 2.18
Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer. Dig Surg (2005) 2.16
Chlamydial infection. Results of tests for Chlamydia in patients suffering from acute Reiter's disease compared with results of tests of the genital tract and rectum in patients with ocular infection due to TRIC agent. Br J Vener Dis (1972) 2.15
Treatment of TRIC infection of the eye with rifampicin or chloramphenicol. Br J Ophthalmol (1977) 2.14
People and eyes: statistical approaches in ophthalmology. Br J Ophthalmol (1998) 2.12
The ecological validity of tests of executive function. J Int Neuropsychol Soc (1998) 2.12
Issues in the design and interpretation of studies to evaluate the impact of community-based interventions. Trop Med Int Health (1997) 2.11
Punctate keratopathy of West Indians. Br J Ophthalmol (1968) 2.11
The management of ocular herpes. Trans Ophthalmol Soc U K (1967) 2.08
Deaths from variant Creutzfeldt-Jakob disease. Lancet (1999) 2.04
Ocular syndromes of TRIC virus infection and their possible genital significance. 1964. Sex Transm Infect (2000) 2.04
Early and late complications after pancreatic necrosectomy. Surgery (2005) 2.03
The impact of maternal depression in pregnancy on early child development. BJOG (2008) 2.02
BD8 certification of visually impaired people. Br J Ophthalmol (1998) 1.96
Is prevalence of diarrhea a better predictor of subsequent mortality and weight gain than diarrhea incidence? Am J Epidemiol (1996) 1.95
Immunological classification of TRIC agents and of some recently isolated LGV agents by the micro-immunofluorescence test. Br J Vener Dis (1972) 1.95
Relation of TRIC agent to "non-specific genital infection". Br J Vener Dis (1966) 1.94
Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology (1996) 1.92
Retirement intentions of doctors who qualified in the United Kingdom in 1974: postal questionnaire survey. J Public Health Med (2001) 1.92
Beta-lactamase of R factors. J Bacteriol (1968) 1.89
Diarrhoea--defining the episode. Int J Epidemiol (1994) 1.87
Chlamydia and non-specific urethritis. Br Med J (1972) 1.82
Characterization of a further microimmunofluorescence serotype of Chlamydia: TRIC type G. Br J Vener Dis (1973) 1.82
Determinants of cataract surgical opportunities and complication rates in UK higher specialist training. Eye (Lond) (2008) 1.79
Cardiovascular effects of hydrocortisone in preterm infants with pressor-resistant hypotension. Pediatrics (2001) 1.78
Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology (2003) 1.78
Corneal and intra-ocular infection due to Fusarium solani. Trans Ophthalmol Soc U K (1970) 1.77
Isolation of TRIC agent (Chlamydia) in irradiated McCoy cell culture from endemic trachoma in field studies in Iran. Comparison with other laboratory tests for detection of Chlamydia. Br J Ophthalmol (1971) 1.72
Patients' choices and perceptions after an invitation to participate in treatment decisions. Soc Sci Med (1992) 1.72
Do insecticide-treated curtains reduce all-cause child mortality in Burkina Faso? Trop Med Int Health (1997) 1.69
Text entry on handheld computers by older users. Ergonomics (2000) 1.69
Principles for the management of penetrating cardiac wounds. Ann Surg (1979) 1.69
An examination of verbal working memory capacity in children with specific language impairment. J Speech Lang Hear Res (1999) 1.69
Vitamin D deficiency in pregnant women from a non-European ethnic minority population--an interventional study. BJOG (2002) 1.64
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharmacol Exp Ther (1999) 1.63
Mycoplasmas and "non-specific" genital infection. II. Clinical aspects. Br J Vener Dis (1969) 1.63
Severe and unrecognised: pertussis in UK infants. Arch Dis Child (2003) 1.62
Ultrastructural studies of early morphogenesis and cytodifferentiation in the embryonic mammalian pancreas. Dev Biol (1968) 1.62
Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill (2011) 1.61
Antenatal domestic violence, maternal mental health and subsequent child behaviour: a cohort study. BJOG (2011) 1.60
Vancomycin for staphylococcal shunt site infections in patients on regular haemodialysis. Br Med J (1970) 1.59
Epidemic keratoconjunctivitis and chronic papillary conjunctivitis in London due to adenovirus type 19. Br J Ophthalmol (1977) 1.58
Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ (2003) 1.56
An economic comparison of hospital-based and community-based glaucoma clinics. Eye (Lond) (2012) 1.55
Monoparesis. Complication of constant positive airways pressure. Arch Dis Child (1975) 1.54
Corticosteroids in the management of herpetic eye disease. Trans Ophthalmol Soc U K (1977) 1.54
Food sensitivity in cats with chronic idiopathic gastrointestinal problems. J Vet Intern Med (2001) 1.54
Prevalence of Neisseria gonorrhoeae infection in young subjects attending community clinics in South London. Sex Transm Infect (2007) 1.53
Does glutamine contribute to immunosuppression after major burns? Lancet (1990) 1.53
Determinants of hemodynamic results of balloon dilation of aortic recoarctation. Am J Cardiol (1992) 1.53
Predictability of the UK variant Creutzfeldt-Jakob disease epidemic. Science (2001) 1.52
Severe malaria in children in Papua New Guinea. QJM (1996) 1.52
Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int (2001) 1.52
Antibiotic treatment of preterm labor with intact membranes: a multicenter, randomized, double-blinded, placebo-controlled trial. Am J Obstet Gynecol (1993) 1.51
Conjunctival impression cytology. Arch Ophthalmol (1977) 1.51
Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis (2000) 1.50